|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,389.85 INR | -2.43% |
|
-4.01% | -6.88% |
| 11/02 | AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| 11/02 | AstraZeneca Pharma India Dec-quarter PAT 325.9 million rupees | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 226.77Cr | |
| 0.67% | 0.75% | 28.95x | 17.84x | 10.91x | 21.91x | 23.33x | 88TCr | |
| 2.19% | 2.32% | 25.63x | 6.65x | 5.96x | 16.23x | 17.93x | 58TCr | |
| 3.16% | 3.28% | 24x | 59.07x | 6.55x | 13.15x | 13.49x | 39TCr | |
| 3.13% | 3.22% | 17.32x | 6.15x | 4.22x | 10.43x | 11.82x | 32TCr | |
| 1.75% | 1.85% | 23.94x | 5.42x | 4.98x | 13.83x | 14.84x | 30TCr | |
| 2.87% | 3% | 20.93x | 6.22x | 5.64x | 13.96x | 14.93x | 29TCr | |
| 2.92% | 3.01% | 27.02x | 5.05x | 4.74x | 14.82x | 17.51x | 29TCr | |
| 2.74% | 2.93% | 24.64x | 16.55x | 6.26x | 11.14x | 14.22x | 20TCr | |
| 2.25% | 2.49% | 20.1x | 6.81x | 6.12x | 11.06x | 13.02x | 18TCr | |
| 4.33% | 4.54% | 11.62x | 5x | 4.21x | 8.75x | 10.2x | 17TCr | |
| 6.61% | 6.65% | 12.44x | 1.66x | 3.16x | 7.54x | 8.91x | 15TCr | |
| 4.26% | 4.38% | 11.81x | 5.16x | 3.11x | 8.38x | 9x | 12TCr | |
| -.--% | -.--% | 26.77x | 5.26x | 8.12x | 18.13x | 18.83x | 12TCr | |
| 3.41% | 3.75% | 12.75x | 4.33x | 2.76x | 7.99x | 9.17x | 11TCr | |
| 5.54% | 5.91% | 11.74x | 1.18x | 2.21x | 7.26x | 7.89x | 11TCr | |
| 2.71% | 1.46% | 36x | 7.78x | 11.64x | 22.87x | 24.38x | 9.65TCr | |
| 3.53% | 3.58% | 50.74x | 1.29x | 2.84x | 10.52x | 29.92x | 5.61TCr | |
| 0.48% | 0.55% | 42.39x | 6x | 9.89x | 33.45x | 34.79x | 5.3TCr | |
| 1.89% | 2.13% | 21.28x | 2.03x | 3.7x | 14.62x | 16.36x | 4.42TCr | |
| Average | 2.86% | 2.94% | 23.69x | 8.92x | 5.63x | 14.00x | 16.34x | 22.25TCr | |
| Weighted average by Cap. | 2.47% | 2.57% | 23.67x | 13.05x | 6.48x | 14.94x | 16.58x |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition